MXPA05008403A - Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion. - Google Patents

Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.

Info

Publication number
MXPA05008403A
MXPA05008403A MXPA05008403A MXPA05008403A MXPA05008403A MX PA05008403 A MXPA05008403 A MX PA05008403A MX PA05008403 A MXPA05008403 A MX PA05008403A MX PA05008403 A MXPA05008403 A MX PA05008403A MX PA05008403 A MXPA05008403 A MX PA05008403A
Authority
MX
Mexico
Prior art keywords
dosage forms
fast
solid dosage
edible acid
pharmaceutical solid
Prior art date
Application number
MXPA05008403A
Other languages
English (en)
Inventor
Tapper Karolyn
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of MXPA05008403A publication Critical patent/MXPA05008403A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Con el fin de reducir el tiempo de desintegracion de formas de dosis farmaceuticas, liofilizadas, de rapida dispersion, orales, solidas, se incluye un acido comestible tal como acido citrico en una composicion usada para producir las formas de dosis donde hay un ingrediente farmaceuticamente activo el cual tiene una baja solubilidad en agua.
MXPA05008403A 2003-02-07 2004-02-09 Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion. MXPA05008403A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/360,905 US20040156894A1 (en) 2003-02-07 2003-02-07 Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
PCT/US2004/004029 WO2004071156A2 (en) 2003-02-07 2004-02-09 Use of edible acid in fast-dispersing pharmaceutical solid dosage forms

Publications (1)

Publication Number Publication Date
MXPA05008403A true MXPA05008403A (es) 2005-10-05

Family

ID=32824085

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008403A MXPA05008403A (es) 2003-02-07 2004-02-09 Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.

Country Status (7)

Country Link
US (1) US20040156894A1 (es)
EP (1) EP1592409A4 (es)
JP (1) JP5403867B2 (es)
AU (1) AU2004210703B2 (es)
CA (1) CA2514650C (es)
MX (1) MXPA05008403A (es)
WO (1) WO2004071156A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
WO2011026080A1 (en) 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
EP2537518A1 (en) * 2011-06-24 2012-12-26 Elanco Animal Health Ireland Limited Fast dissolving azaperone granulate formulation
CN103877041B (zh) * 2014-03-14 2016-07-06 崔书豪 一种吡罗昔康分散片及其制备方法
US11026883B2 (en) * 2016-10-13 2021-06-08 Catalent U.K. Swindon Zydis Limited Lyophilized pharmaceutical compositions for vaginal delivery
JP6868698B2 (ja) 2016-12-31 2021-05-12 バイオエクセル セラピューティクス，インコーポレイテッド 激越の治療のための舌下デクスメデトミジンの使用
CN107126442B (zh) * 2017-05-09 2018-06-05 葵花药业集团(衡水)得菲尔有限公司 一种小儿氨酚黄那敏颗粒制备工艺
MX2020014000A (es) 2018-06-27 2021-06-15 Bioxcel Therapeutics Inc Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US11672761B2 (en) * 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
JPS5939834A (ja) * 1982-08-31 1984-03-05 Morishita Jintan Kk 製剤用皮膜組成物
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
JPH0774150B2 (ja) * 1987-07-31 1995-08-09 新田ゼラチン株式会社 肝油用ソフトカプセル
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
GB9504201D0 (en) * 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
WO1997038679A2 (en) * 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US5712310A (en) * 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
GB9702799D0 (en) * 1997-02-12 1997-04-02 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms
FR2759587B1 (fr) * 1997-02-20 1999-03-19 Synthelabo Composition pharmaceutique pour l'administration buccale de thiocolchicoside
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
ES2263216T3 (es) * 1997-07-25 2006-12-01 Alpex Pharma S.A. Procedimiento para la preparacion de un granulado adecuado para la preparacion de comprimidos solubles en la boca rapidamente disgregables.
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
ATE254918T1 (de) * 1998-04-02 2003-12-15 Akzo Nobel Nv Orale flüssige lösung enthaltend das antidepressivum mirtazapine
EP1121103B1 (en) * 1998-05-18 2006-12-20 Takeda Pharmaceutical Company Limited Orally disintegrable tablets comprising a benzimidazole
US6261583B1 (en) * 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2000054752A1 (fr) * 1999-03-15 2000-09-21 Kaken Pharmaceutical Co., Ltd. Comprimes a delitement rapide et procede de fabrication
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
BR0008058A (pt) * 1999-12-08 2002-03-26 Pharmacia Corp Forma de estado sólido de celecoxib tendo biodisposnibilidade melhorada
JP2003523954A (ja) * 1999-12-08 2003-08-12 ファルマシア コーポレイション 治療効果が迅速に開始されるシクロオキシゲナーゼ−２阻害剤組成物
WO2002045684A2 (en) * 2000-12-06 2002-06-13 Pharmacia Corporation Rapidly dispersing pharmaceutical composition comprising effervescent agents
JP4739217B2 (ja) * 2003-05-07 2011-08-03 サムヤン コーポレイション 速く溶ける錠剤を製造するための高可塑性顆粒

Also Published As

Publication number Publication date
EP1592409A2 (en) 2005-11-09
JP5403867B2 (ja) 2014-01-29
AU2004210703A1 (en) 2004-08-26
EP1592409A4 (en) 2007-10-31
WO2004071156A2 (en) 2004-08-26
WO2004071156A3 (en) 2004-12-02
JP2006517236A (ja) 2006-07-20
CA2514650C (en) 2014-01-07
CA2514650A1 (en) 2004-08-26
US20040156894A1 (en) 2004-08-12
AU2004210703B2 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
WO2004012700A3 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
IT1276689B1 (it) Forma farmaceutica solida ad uso orale
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
BR0115985A (pt) Preparação farmacêutica em forma de uma pasta compreendendo um ingrediente ativo ácido-lábil
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
EA200501901A1 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путём
CA2429639A1 (en) Stable azithromycin monohydrate
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
WO2005065639A3 (en) Novel pharmaceutical compositions
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
MXPA05008843A (es) Sistema terapeutico que comprende amoxicilina y acido clavulanico.
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
EA200600156A1 (ru) Пероральная дозировочная форма саквинавирмезилата
WO2004014318A3 (en) Levothyroxine compositions and methods

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration